Location History:
- Dover, MA (US) (1998)
- Westboro, MA (US) (2001 - 2003)
- Milford, MA (US) (2005 - 2019)
- Bolton, MA (US) (2021 - 2024)
Company Filing History:
Years Active: 1998-2024
Title: Inventor Profile: Dallas E. Hughes
Introduction
Dallas E. Hughes is a prominent inventor based in Westboro, Massachusetts, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Hughes has focused much of his research on novel depsipeptides and their various applications in treating disorders.
Latest Patents
Among his latest patents, Hughes has developed innovative methods related to depsipeptides. His invention, titled "Depsipeptides and Uses Thereof," encompasses novel depsipeptides, methods for their preparation, and pharmaceutical compositions. This invention also focuses on using these depsipeptides for treating or inhibiting various disorders, showcasing his commitment to advancing medical science through innovative technologies.
Career Highlights
Throughout his career, Dallas E. Hughes has played a vital role in the pharmaceutical sector. He has held significant positions at Novobiotic Pharmaceuticals, LLC and Cetek Corporation. His experiences in these companies have shaped his research and development endeavors, contributing to his recognition as an influential inventor in his field.
Collaborations
Collaborating with other talented professionals has been a key aspect of Hughes' success. He has worked alongside colleagues such as Aaron J. Peoples and Losee Lucy Ling, which has enriched his research efforts and expanded the horizons of his inventions. Their teamwork exemplifies the importance of collaboration in the pursuit of innovative solutions.
Conclusion
Dallas E. Hughes stands out as a noteworthy inventor with a robust portfolio in pharmaceutical inventions. His focus on depsipeptides illustrates his dedication to developing effective treatments for various medical conditions. With his continued efforts and collaboration with skilled professionals, Hughes is poised to further impact the field of pharmaceuticals and innovation.